Sebacic acid

Sebacic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 680 references associated with Sebacic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Sebacic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sebacic acid

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Sebacic acid

Download all related citations
Per page 10 20 50 100 | Total 172
Authors Title Published Journal PubMed Link
pmid:
Santos CA et al. Poly(fumaric-co-sebacic anhydride). A degradation study as evaluated by FTIR, DSC, GPC and X-ray diffraction. 1999 J Control Release pmid:10370167
Muggli DS et al. Crosslinked polyanhydrides for use in orthopedic applications: degradation behavior and mechanics. 1999 J. Biomed. Mater. Res. pmid:10380006
Teomim D et al. Ricinoleic acid-based biopolymers. 1999 J. Biomed. Mater. Res. pmid:10397984
Hagen T et al. A GC/MS/MS screening method for multiple organic acidemias from urine specimens. 1999 Clin. Chim. Acta pmid:10404733
Capristo E et al. A new HPLC method for the direct analysis of triglycerides of dicarboxylic acids in biological samples. 1999 Clin. Chim. Acta pmid:10556649
Stephens D et al. Investigation of the in vitro release of gentamicin from a polyanhydride matrix. 2000 J Control Release pmid:10601726
Favuzzi AM et al. Pharmacokinetics of sebacic acid in rats. 1999 May-Jun Eur Rev Med Pharmacol Sci pmid:10827815
Taulbee DB and Yu CP A theory of aerosol deposition in the human respiratory tract. 1975 J Appl Physiol pmid:1110247
Yuan X et al. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas. 2001 Int. J. Cancer pmid:11291095
Kervinen J et al. Mechanistic basis for suicide inactivation of porphobilinogen synthase by 4,7-dioxosebacic acid, an inhibitor that shows dramatic species selectivity. 2001 Biochemistry pmid:11444968
Gardon M et al. The lock-in phase in the urotropine-sebacic acid system. 2001 Acta Crystallogr C pmid:11498619
Arosio D et al. Static and dynamic light scattering approach to the hydration of hemoglobin and its supertetramers in the presence of osmolites. 2002 Biopolymers pmid:11754343
pmid:11790496
Jaffe EK et al. Species-specific inhibition of porphobilinogen synthase by 4-oxosebacic acid. 2002 J. Biol. Chem. pmid:11909869
Chan CK and Chu IM Phase behavior and miscibility in blends of poly(sebacic anhydride)/poly(ethylene glycol). 2002 Biomaterials pmid:12013182
Wang Y et al. A tough biodegradable elastomer. 2002 Nat. Biotechnol. pmid:12042865
Fleming AB and Saltzman WM Pharmacokinetics of the carmustine implant. 2002 Clin Pharmacokinet pmid:12074689
Slivniak R and Domb AJ Stereocomplexes of enantiomeric lactic acid and sebacic acid ester-anhydride triblock copolymers. 2002 Jul-Aug Biomacromolecules pmid:12099819
Fu J et al. New polymeric carriers for controlled drug delivery following inhalation or injection. 2002 Biomaterials pmid:12219833
Heyder J and Rudolf G Deposition of aerosol particles in the human nose. 1975 Inhaled Part pmid:1236151
Yu CP and Taulbee DB A theory of predicting respiratory tract deposition of inhaled particles in man. 1975 Inhaled Part pmid:1236168
Tian Y et al. The effect of storage temperatures on the in vitro properties of a polyanhydride implant containing gentamicin. 2002 Drug Dev Ind Pharm pmid:12378959
Harris JR In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition. 2002 Micron pmid:12475558
Najafi F and Sarbolouki MN Biodegradable micelles/polymersomes from fumaric/sebacic acids and poly(ethylene glycol). 2003 Biomaterials pmid:12527258
Yang XF et al. In vitro release and antibacterial activity of poly (oleic/linoleic acid dimer: sebacic acid)-gentamicin. 2003 Acta Pharmacol. Sin. pmid:12676068
Muth A et al. Simultaneous enantioselective analysis of chiral urinary metabolites in patients with Zellweger syndrome. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12860034
Sherwood JK et al. Controlled antibody delivery systems. 1992 Biotechnology (N.Y.) pmid:1369022
PACKETT LV and MCCUNE RW DETERMINATION OF STEAM-VOLATILE ORGANIC ACIDS IN FERMENTATION MEDIA BY GAS-LIQUID CHROMATOGRAPHY. 1965 Appl Microbiol pmid:14264844
UbaÄ­dullaev RU et al. [Toxicological characteristics of sebacic acid and the substantiation of its maximum permissible exposure level in atmospheric air]. 1992 Gig Sanit pmid:1427150
D'Emanuele A et al. Molecular weight changes in polymer erosion. 1992 Pharm. Res. pmid:1448426
Tataranni PA et al. Tracer study of metabolism and tissue distribution of sebacic acid in rats. 1992 Ann. Nutr. Metab. pmid:1492757
Shikanov A et al. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. 2004 J Biomed Mater Res A pmid:14999750
Fiegel J et al. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. 2004 J Control Release pmid:15120898
Deng J et al. Effect of postmolding heat treatment on in vitro properties of a polyanhydride implant containing gentamicin sulfate. 2004 Drug Dev Ind Pharm pmid:15132176
Ulezlo IV and Rogozhin IS [Search for yeast producers of brassylic and sebacic fatty acids]. 2004 Sep-Oct Prikl. Biokhim. Mikrobiol. pmid:15553784
Li H et al. [Spectroscopy studies on the interaction of bis(p-nitrophenyl) esters and beta-cyclodextrin]. 2005 Guang Pu Xue Yu Guang Pu Fen Xi pmid:15852862
Greco AV et al. Metabolic effects and disposition of sebacate, an alternate dicarboxylic fuel substrate. 1992 Ann. Nutr. Metab. pmid:1590667
Kim MS et al. Synthesis and characterization of polyanhydride for local BCNU delivery carriers. 2005 Biomed Mater Eng pmid:15912003
pmid:15963960
Krasko MY and Domb AJ Hydrolytic degradation of ricinoleic-sebacic-ester-anhydride copolymers. 2005 Jul-Aug Biomacromolecules pmid:16004424
Jiang H et al. Novel copolyanhydrides combining strong inherent fluorescence and a wide range of biodegradability: synthesis, characterization and in vitro degradation. 2005 Macromol Biosci pmid:16096992
Determan AS et al. Protein stability in the presence of polymer degradation products: consequences for controlled release formulations. 2006 Biomaterials pmid:16504288
Modi S et al. Copolymers of pharmaceutical grade lactic acid and sebacic acid: drug release behavior and biocompatibility. 2006 Eur J Pharm Biopharm pmid:16846724
Jampel HD et al. In vitro release of hydrophobic drugs from polyanhydride disks. 1991 Ophthalmic Surg pmid:1686489
KarakuÅŸ E et al. A new potentiometric ammonium electrode for biosensor construction. 2006 Artif Cells Blood Substit Immobil Biotechnol pmid:16893815
Mingrone G et al. Use of even-numbered carbon atom dicarboxylic salts in parenteral nutrition as fuel substrate. 1992 Jan-Feb JPEN J Parenter Enteral Nutr pmid:1738216
Gong K et al. Synthesis of poly(sebacic anhydride)-indomethacin controlled release composites via supercritical carbon dioxide assisted impregnation. 2007 Int J Pharm pmid:17398049
Hou S et al. Synthesis and erosion properties of PEG-containing polyanhydrides. 2007 Macromol Biosci pmid:17457940
Lee WC and Chu IM Preparation and degradation behavior of polyanhydrides nanoparticles. 2008 J. Biomed. Mater. Res. Part B Appl. Biomater. pmid:17474078